Pancreatic Cancer Research

ResearcherJohns Hopkins UniversityActive in the last 2 years

A. Floortje van Oosten

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2410-3779; OpenAlex author ID A5035434097. Sources: OpenAlex.

Their work

Papers
10 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
68
Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper · 2021: none · 2022: 3 papers · 2023: 3 papers · 2024: 1 paper · 2025: none · 2026: 1 paper

Papers 10

  1. Survival benefit of recurrence-focused treatment after surgery for pancreatic ductal adenocarcinoma: A propensity score matched analysis of patients from a Dut… First author DOI 10.1016/j.ejca.2026.117776↗
  2. Dynamics of Serum CA19-9 in Patients Undergoing Pancreatic Cancer Resection. Co-author DOI 10.1097/sla.0000000000005977↗
  3. Predicting post-recurrence survival for patients with pancreatic cancer recurrence after primary resection: A Bi-institutional validated risk classification. Co-author DOI 10.1016/j.ejso.2023.04.009↗
  4. Early Recurrence After Resection of Locally Advanced Pancreatic Cancer Following Induction Therapy: An International Multicenter Study. First author DOI 10.1097/sla.0000000000005666↗
  5. A Delay in Adjuvant Therapy Is Associated With Worse Prognosis Only in Patients With Transitional Circulating Tumor Cells After Resection of Pancreatic Ductal … First author DOI 10.1097/sla.0000000000005710↗
  6. Association of Matrix Metalloproteinase 7 Expression With Pathologic Response After Neoadjuvant Treatment in Patients With Resected Pancreatic Ductal Adenocarc… Co-author DOI 10.1001/jamasurg.2022.1362↗
  7. Preoperative predictors for early and very early disease recurrence in patients undergoing resection of pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.hpb.2021.09.004↗
  8. Comprehensive Analysis of Somatic Mutations in Driver Genes of Resected Pancreatic Ductal Adenocarcinoma Reveals KRAS G12D and Mutant TP53 Combination as an In… Co-author DOI 10.1245/s10434-021-11081-z↗
  9. Pattern of Invasion in Human Pancreatic Cancer Organoids Is Associated with Loss of SMAD4 and Clinical Outcome. Co-author DOI 10.1158/0008-5472.can-19-1523↗
  10. Isolated pulmonary recurrence after resection of pancreatic cancer: the effect of patient factors and treatment modalities on survival. Co-author DOI 10.1016/j.hpb.2018.12.002↗

Closest collaborators

The 25 strongest of 68 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Vincent P. Groot · 8 shared papers, 2019–2026 · strength 1.15
  2. Jin Peng He · 7 shared papers, 2019–2026 · strength 1.03
  3. Izaak Quintus Molenaar · 6 shared papers, 2019–2026 · strength 0.92
  4. Lois A. Daamen · 5 shared papers, 2022–2026 · strength 0.83
  5. Hjalmar C. van Santvoort · 5 shared papers, 2022–2026 · strength 0.83
  6. Richard Andrew Burkhart · 6 shared papers, 2019–2024 · strength 0.83
  7. Joseph R. Habib · 5 shared papers, 2022–2026 · strength 0.81
  8. Christopher Lee Wolfgang · 5 shared papers, 2019–2024 · strength 0.66
  9. Ammar A. Javed · 4 shared papers, 2022–2026 · strength 0.65
  10. Benedict Kinny‐Köster · 4 shared papers, 2022–2023 · strength 0.60
  11. Christopher L. Wolfgang · 3 shared papers, 2022–2023 · strength 0.45
  12. Bas Groot Koerkamp · 3 shared papers, 2022–2026 · strength 0.45
  13. Marc G. Besselink · 3 shared papers, 2022–2026 · strength 0.45
  14. Martijn W.J. Stommel · 3 shared papers, 2022–2026 · strength 0.45
  15. Kelly J. Lafaro · 3 shared papers, 2022–2023 · strength 0.44
  16. Iris W.J.M. van Goor · 2 shared papers, 2023–2026 · strength 0.37
  17. Robert C. Verdonk · 2 shared papers, 2022–2026 · strength 0.32
  18. Vincent Erwin de Meijer · 2 shared papers, 2022–2026 · strength 0.32
  19. Bert A. Bonsing · 2 shared papers, 2022–2026 · strength 0.32
  20. Jing He · 2 shared papers, 2023 · strength 0.29
  21. Ning Pu · 2 shared papers, 2022 · strength 0.28
  22. Sami Shoucair · 2 shared papers, 2022 · strength 0.28
  23. Jun Yu · 2 shared papers, 2022 · strength 0.28
  24. Lilly J. H. Brada · 2 shared papers, 2022–2023 · strength 0.24
  25. Ignace H. J. T. de Hingh · 2 shared papers, 2022–2023 · strength 0.24

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.